Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • March4NETs
NET Nurse
Donate

Home » News » Melbourne NET Forum 2024

Melbourne NET Forum 2024

  • November 29, 2024
Watch the forum HERE
On Thursday 28th November 2024, NeuroEndocrine Cancer Australia (NECA) facilitated the Melbourne NET Patient Forum at Peter MacCallum Cancer Centre.
 
We had a great turn out with over 30 patients, family, friends and carers attending the event. The forum went for two hours, and it was a full evening with amazing presenters, questions and discussions.  
 
The agenda included a diverse range of topics including:
  • Professor Michael Michael, Medical Oncologist at Peter MacCallum Cancer Centre gave an overview of NETS, an update on Medical Oncology & Clinical trials.
  • Associate Professor Grace Kong is a Nuclear Medicine Physician at Peter MacCallum Cancer Centre gave an overview of what Peptide Receptor Radionuclide Therapy is, then an update on Nuclear Medicine & Clinical Trials.
  • Associate Professor Cherie Chiang, Endocrinologist & Chemical Pathologist, provided an informative overview on guideline updates of symptoms and risk factors for carcinoid crisis in surgery / procedures and the development of spot urine 5HIAA which included food restrictions & timeframes for the test.
  • Dr Erin Laing is a NET Specialist Dietitian who works at the Peter MacCallum Cancer Centre who gave an insightful overview on nutrition and current research & guidelines available.
  • Kate Wakelin, NET Clinical Nurse Consultant at Peter MacCallum Cancer Centre provided an overview on the NET Nurse Clinic at Peter Mac.
  • Meredith Cummins, CEO of NECA, then provided an insightful update on NECA and facilitated Q & A time, which included some great discussions.
Thank you to everyone who attended the Melbourne NET Patient Forum and a big thank you to our guest speakers.
 

Click here to view the Forum.

IMG_0559
IMG_0547
IMG_0541
IMG_0536
Melbourne Forum
PXL_20241128_092400473.MP~2

Share this post

Recent posts

VHL Awareness Month 2025

May 6, 2025

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

May 5, 2025

Help Us Grow: Connect NECA with Corporate Partners to Make a Lasting Impact

April 29, 2025

Neuroendocrine Cancer Awareness Daily Mail 5 April 2025

April 5, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousBridging funding to enable faster access to medicines in Australia
NextBelzutifan listed on PBS 1st December 2024Next

Related Posts

VHL Awareness Month 2025

May is internationally recognised as Von Hippel-Lindau (VHL) Awareness Month—a time to highlight this rare genetic, and in some case not genetic, condition and the

NET Patient Chris, from Ballarat, Raises Awareness of Neuroendocrine Cancer

NeuroEndocrine Cancer Australia (NECA) is proud to recognise the advocacy efforts of NET patient Chris Geljon, who has taken the time to raise awareness of

Neuroendocrine Cancer Awareness Daily Mail 5 April 2025

Jo O’Halloran was in her early fifties when the symptoms she and her friends had heard so much about started to appear. ‘I was always

Neuroendocrine Cancer in Budget 2025–26

The 2025–26 Federal Budget, delivered by the Treasurer Hon Jim Chalmers on 25th March, included a welcome investment of $256.2 million over four years from 2025–26 (and

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin